ACADIAN ASSET MANAGEMENT LLC - FREELINE THERAPEUTICS HLDGS ownership

Back to all holdings Add to watchlist

FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 1 filers reported holding FREELINE THERAPEUTICS HLDGS in Q3 2023. The put-call ratio across all filers is - and the average weighting 9.3%.

Links
Filings
External links
Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of FREELINE THERAPEUTICS HLDGS
ValueSharesWeighting
Q1 2023$120.0%26,9630.0%0.00%–
Q4 2022$12
-99.9%
26,9630.0%0.00%–
Q3 2022$18,000
-21.7%
26,9630.0%0.00%–
Q2 2022$23,000
-23.3%
26,9630.0%0.00%–
Q1 2022$30,000–26,963–0.00%–
 Download
Other shareholders
FREELINE THERAPEUTICS HLDGS shareholders Q3 2023
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 1,466,507$6,217,9909.26%
View complete list of FREELINE THERAPEUTICS HLDGS shareholders